Funding opportunities
319 live opportunities from Grants.gov, NIH, NSF, and more.
Mathematics & Statistics× remove
- Optimizing gamma-delta T cell receptor-mediated signaling to improve cancer immunotherapyNational Cancer InstitutePAR-25-078 closes 5/31/2028up to $156,000activenih
- Personalized Spatial Regulatory Networks to Decode Breast Cancer MicroenvironmentsNational Cancer InstitutePAR-25-078 closes 5/31/2028up to $178,000activenih
- A PROTAC Strategy to Combat Botulinum NeurotoxicityNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $518,450activenih
- Peptidoglycan modification activating NOD2 in N. gonorrhoeae infectionsNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $233,250activenih
- Functional Brain Signatures of Learning Disabilities Across DevelopmentEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-24-194 closes 5/31/2028up to $127,926activenih
- How Feedback Shapes Sensory Representations During CognitionNational Institute of Neurological Disorders and StrokeRFA-NS-24-030 closes 5/31/2028up to $44,714activenih
- Fluorescence lifetime imaging for quantitative assessment of in vivo PD-L1 target engagement.National Cancer InstitutePAR-25-346 closes 5/31/2028up to $437,113activenih
- A general method for converting antibodies into fluorescent sensors of their antigensNational Institute of Allergy and Infectious DiseasesPA-25-304 closes 5/31/2028up to $405,202activenih
- Herpes Simplex Immunotherapeutic Targeting CD8 T cellsNational Institute of Allergy and Infectious DiseasesRFA-AI-24-068 closes 5/31/2028up to $256,074activenih
- Harnessing antibody-driven bioconjugation to modulate immune functionNational Institute of Allergy and Infectious DiseasesPA-24-194 closes 5/31/2028up to $182,196activenih
- Fully recombinant, highly potent heptavalent botulinum antitoxin with ambient temperature stabilityNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $491,985activenih
- Next Generation pan-serotype,antitoxin for botulinum neurotoxin exposuresNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $531,688activenih
- The impact of tau on RNA and translation in progressive supranuclear palsyNational Institute on AgingPA-20-195 closes 5/31/2028up to $422,125activenih
- Prime editing therapeutics for LGMD2iEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentPA-25-304 closes 5/31/2028up to $460,625activenih
- Improved Aminopyridine Analogs for Symptomatic Treatment of BotulismNational Institute of Allergy and Infectious DiseasesRFA-AI-24-080 closes 5/31/2028up to $480,448activenih
- Transcriptomic, Genomic, and Microenvironmental Heterogeneity in pancreatic precancer: subtyping, classification, and cross-comparisonNational Cancer InstitutePAR-23-286 closes 5/31/2028up to $123,823activenih
- Quantitative Predictive Dosimetry for Curative Transarterial RadioembolizationNational Cancer InstitutePAR-25-135 closes 5/31/2028up to $161,460activenih
- Evaluating the Synergistic Therapeutic Effects of Retinoic Acid and the Proteasome Inhibitors in NeuroblastomaNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $467,968activenih
- Perfusion CT for liver radioembolizationNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $409,141activenih
- Development of Cdc14 inhibitors as novel antifungal agents against diverse fungal pathogensNational Institute of Allergy and Infectious DiseasesRFA-AI-24-065 closes 5/31/2028up to $229,127activenih
- New tricks from old genes: Investigating G-protein signaling as a mediator of colony morphology and aerobic glycolysis in Aspergillus fumigatusNational Institute of Allergy and Infectious DiseasesPA-25-422 closes 5/31/2028up to $50,114activenih
- Fragment-based targeting of EMT-mediated resistance in EGFR-mutant lung cancerNational Cancer InstitutePAR-25-139 closes 5/31/2028up to $433,256activenih
- Using Artificial Intelligence to Estimate Personal Symptom Network for Cancer Survivorship CareNational Cancer InstitutePA-25-253 closes 5/31/2028up to $491,925activenih
- Effect of HIV Infection on Sickle Cell Disease Outcomes (EFHISA)John E. Fogarty International Center for Advanced Study in the Health SciencesPAR-23-191 closes 5/31/2028up to $156,179activenih
- Substances, Behaviors, and Outcomes of Adolescent Reporting to a Statewide Technology-Facilitated Reporting SystemNational Institute on Drug AbusePA-25-304 closes 5/31/2028up to $429,000activenih